Mohamad Mohty, Head of the Clinical Hematology and Cellular Therapy Department at Saint-Antoine Hospital, Sorbonne University, shared a post on X:
“At ASCO26, one message was impossible to ignore: AI is no longer a future promise in oncology; it is becoming a partner across the entire cancer journey. The question is no longer if we should use AI, but how we can use it responsibly and fit-for-purpose.”
Other articles featuring Mohamad Mohty on OncoDaily.